Cipta Sarana Medika Tbk. vs Mahkota Group Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Mahkota Group Tbk. trades at Rp675 (market cap 2.4T, 3.5M 24h volume). The key difference: Mahkota Group Tbk. is far larger — about 15.2× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 3.5M). Which is the better fit depends on your goals.
| DKHH | MGRO | |
|---|---|---|
Market Cap | 158.12B | 2.4T |
Volume | 8.21M | 3.5M |
Lot | 82.15K | 35.02K |
Turnover | 515.2M | 2.35B |
Average Price | 62.72 | 670.59 |
Value | 515.2M | 2.35B |
Indicative Equilibrium Price | 63 | 675 |
Indicative Equilibrium Volume | 1.33K | 493 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Mahkota Group (the Company) was established based on Deed No. 7 dated January 7, 2011 of Cipto Soenaryo, S.H., Notary in Medan.
Read more on MGRO →